A wound dressing is not a treatment by itself. It is an interface between your wound and the outside world, and its job changes depending on where your wound is in the healing process. At Wound Care Specialists, we select from a range of medical-grade dressings and biologic products based on your wound's healing phase, fluid output, tissue condition, and specific barriers to healing.
Advanced Dressings
Modern wound dressings do far more than cover a wound. They regulate moisture, manage drainage, protect new tissue, deliver antimicrobial agents, and in some cases provide structural scaffolding that supports your body's repair process. The key is matching the dressing to the wound's current needs.
Foam dressings absorb moderate amounts of drainage while maintaining a moist wound environment. They cushion the wound and are commonly used during the building phase when granulation tissue is forming.
Alginate and hydrofiber dressings are designed for wounds with heavy drainage. Made from seaweed-derived fibers or specialized cellulose, they absorb large volumes of fluid and form a gel that conforms to the wound bed. These are often used during the cleaning phase or in highly exudative wounds.
Hydrogel dressings donate moisture to dry wounds and support autolytic debridement by softening dead tissue. They are particularly useful for wounds that lack adequate fluid or for painful wounds where a cooling, soothing interface improves comfort.
Collagen and oxidized regenerated cellulose (ORC) dressings are used in wounds where excess protease activity is breaking down new tissue faster than the body can build it. These dressings bind and deactivate destructive enzymes (particularly MMP-8 and MMP-9), creating a more favorable environment for tissue growth.
Antimicrobial dressings containing silver, iodine, or other agents help control bacterial burden at the wound surface. We use these selectively, because prolonged exposure to silver or iodine can be toxic to the fibroblasts your wound needs for repair. They are tools for specific situations, not default choices.
Biologic Therapies
For wounds that have stalled despite proper debridement, infection control, and dressing management, biologic therapies can provide the additional support needed to restart progress. These include:
Amniotic membrane allografts contain an extracellular matrix reservoir rich in anti-inflammatory proteins and growth factors. They are applied directly to the wound bed, typically weekly or biweekly over a course of four to eight weeks, and are commonly used for diabetic foot ulcers and venous leg ulcers that have moved into the building phase.
Collagen-based matrices provide structural scaffolding that supports cell migration and new tissue formation. Some also bind excess proteases, addressing one of the most common reasons chronic wounds fail to progress.
Growth factor therapies deliver concentrated signaling proteins to the wound site, stimulating the cellular activity needed for tissue repair.
Timing is critical with all biologic products. Applied to a wound that still harbors infection, unmanaged inflammation, or uncontrolled systemic health issues, even the most advanced product will fail. We follow a phase-gated approach: biologics are introduced only after the wound has been moved through the cleaning phase and systemic barriers (blood sugar, nutrition, circulation, edema) have been addressed. This sequencing is what separates effective use of these products from expensive failure.
Who It Helps
Any patient with a chronic wound benefits from phase-appropriate dressing selection. Biologic therapies are typically reserved for wounds that have not responded to standard treatment after four or more weeks of care, particularly diabetic foot ulcers, venous leg ulcers, and pressure injuries that have stalled in the building phase despite adequate debridement and systemic optimization.
You may be a candidate for biologic therapy if your wound bed is clean and well-perfused but tissue growth has plateaued, or if your wound has failed to achieve at least 40 percent area reduction within four weeks of consistent treatment.
Your Visit
Here's what treatment looks like from your first visit through recovery.
Dressing selection happens at every visit. Your clinician evaluates the wound's tissue type, drainage volume, signs of infection, and healing phase before choosing or adjusting the dressing. This is not a set-it-and-forget-it process. As your wound changes, so does the dressing.
If biologic therapy is recommended, the product is applied directly to the wound bed during a clinic visit. The procedure is typically painless. A secondary dressing is placed over it, and you'll receive instructions for wound care at home.
Follow-up visits are scheduled to monitor how the tissue is integrating and whether the wound is responding. We expect to see measurable progress (30 to 50 percent area reduction) within four to six weeks of biologic application. If that benchmark isn't met, we reassess the wound and the treatment plan.
Your wound's needs change as it heals. A dressing designed to absorb heavy drainage may dry out a wound that has moved into a later healing phase. Your clinician reassesses the wound at every visit and selects the dressing that matches its current condition.
Biologics are materials derived from human or animal tissue (such as amniotic membrane or collagen) that provide growth factors, structural support, or anti-inflammatory properties to a wound. They are FDA-regulated and applied in a clinical setting to support tissue repair.
Biologics are considered when a wound has not made adequate progress after four or more weeks of standard care, assuming the wound bed is clean and systemic health factors have been addressed. Your clinician will discuss whether a biologic product is appropriate based on your wound's trajectory.
No. Application is similar to placing a dressing on the wound. Most patients feel little to no discomfort during the process.
If your wound has stalled or you're unsure whether your current treatment plan is working, request a consultation with our team.